Profile data is unavailable for this security.
About the company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
- Revenue in USD (TTM)7.69m
- Net income in USD-67.71m
- Incorporated2004
- Employees168.00
- LocationMolecular Partners AGWagistrasse 14SCHLIEREN 8952SwitzerlandCHE
- Phone+41 447557700
- Fax+41 447557707
- Websitehttps://www.molecularpartners.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaxart Inc | 7.38m | -82.47m | 123.89m | 109.00 | -- | 1.86 | -- | 16.79 | -0.5844 | -0.5844 | 0.0519 | 0.3767 | 0.0601 | -- | 4.87 | 67,697.25 | -67.13 | -49.60 | -77.06 | -54.86 | -- | -- | -1,117.56 | -1,398.00 | -- | -- | 0.10 | -- | 6,796.26 | 12.15 | 23.47 | -- | 21.49 | -- |
| Adicet Bio Inc | 0.00 | -142.66m | 124.90m | 143.00 | -- | 0.3865 | -- | -- | -3.32 | -3.32 | 0.00 | 3.93 | 0.00 | -- | -- | 0.00 | -53.03 | -37.03 | -57.18 | -40.28 | -- | -- | -- | -748.46 | -- | -- | 0.00 | -- | -100.00 | -- | -104.41 | -- | 65.27 | -- |
| Leap Therapeutics Inc | 0.00 | -81.41m | 125.11m | 54.00 | -- | 1.39 | -- | -- | -5.11 | -5.11 | 0.00 | 2.35 | 0.00 | -- | -- | 0.00 | -113.72 | -80.06 | -136.52 | -95.03 | -- | -- | -- | -7,900.37 | -- | -- | 0.00 | -- | -- | -- | -49.12 | -- | -- | -- |
| Karyopharm Therapeutics Inc | 146.03m | -143.10m | 125.78m | 325.00 | -- | -- | -- | 0.8613 | -1.25 | -1.25 | 1.28 | -1.19 | 0.4879 | 1.36 | 3.94 | 449,332.30 | -47.81 | -53.02 | -61.78 | -65.85 | 96.62 | 97.18 | -97.99 | -125.15 | 3.32 | -10.06 | 1.81 | -- | -7.03 | 36.93 | 13.43 | -- | -- | -- |
| Coya Therapeutics Inc | 6.00m | -7.99m | 126.60m | 8.00 | -- | 3.50 | -- | 21.09 | -0.8219 | -0.8219 | 0.5906 | 2.47 | 0.2417 | -- | -- | 750,276.30 | -32.17 | -- | -39.17 | -- | -- | -- | -133.08 | -- | -- | -- | 0.00 | -- | -- | -- | 34.77 | -- | -- | -- |
| FitLife Brands Inc | 52.70m | 5.30m | 127.60m | 37.00 | 25.66 | 4.72 | 23.67 | 2.42 | 1.08 | 1.08 | 10.74 | 5.88 | 1.30 | 3.44 | 38.31 | 1,424,297.00 | 13.07 | 26.40 | 15.94 | 33.92 | 40.67 | 42.09 | 10.05 | 17.65 | 0.5419 | 16.81 | 0.4253 | -- | 82.97 | 25.28 | 19.58 | 67.31 | -- | -- |
| Vistagen Therapeutics Inc | 1.04m | -32.07m | 128.10m | 37.00 | -- | 1.04 | -- | 122.90 | -3.56 | -3.56 | 0.0775 | 4.56 | 0.013 | -- | -- | 31,584.85 | -39.89 | -77.80 | -42.10 | -85.00 | -- | -- | -3,076.62 | -8,640.25 | -- | -- | 0.00006 | -- | -120.50 | -- | -21.64 | -- | 165.73 | -- |
| Molecular Partners AG (ADR) | 7.69m | -67.71m | 130.16m | 168.00 | -- | 0.6597 | -- | 16.93 | -2.07 | -2.07 | 0.2345 | 5.87 | 0.0306 | -- | 4.74 | 45,764.54 | -26.91 | -11.83 | -28.90 | -14.69 | -- | 99.28 | -880.70 | -45.30 | -- | -70.97 | 0.0203 | -- | -96.29 | -7.43 | -152.59 | -- | -1.40 | -- |
| Citius Pharmaceuticals Inc | 0.00 | -39.33m | 131.02m | 22.00 | -- | 1.36 | -- | -- | -0.255 | -0.255 | 0.00 | 0.533 | 0.00 | -- | -- | 0.00 | -36.52 | -30.26 | -38.61 | -32.11 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.1589 | -- | -- | -- |
| Sagimet Biosciences Inc | 2.00m | -27.88m | 131.17m | 10.00 | -- | 1.03 | -- | 65.59 | -1.31 | -1.31 | 0.0937 | 3.98 | -- | -- | -- | 200,000.00 | -- | -- | -- | -- | -- | -- | -1,393.80 | -- | -- | -- | 0.00 | -- | -- | -- | 8.60 | -- | -- | -- |
| Amylyx Pharmaceuticals Inc | 380.79m | 49.27m | 131.25m | 384.00 | 2.74 | 0.3015 | 2.61 | 0.3447 | 0.7045 | 0.7045 | 5.43 | 6.40 | 0.8379 | 1.06 | 13.76 | 991,630.20 | 10.84 | -- | 12.63 | -- | 93.32 | -- | 12.94 | -- | 5.20 | -- | 0.00 | -- | 1,612.94 | -- | 124.84 | -- | -- | -- |
| Elite Pharmaceuticals Inc | 47.32m | 15.55m | 131.42m | 53.00 | 8.46 | 2.83 | 7.77 | 2.78 | 0.0153 | 0.0153 | 0.0465 | 0.0456 | 0.7428 | 2.24 | 4.39 | 892,785.50 | 24.41 | 3.53 | 30.62 | 4.61 | 45.82 | 46.10 | 32.87 | 4.41 | 1.19 | 1.18 | 0.1449 | 0.00 | 5.87 | 35.57 | -59.97 | -- | 83.62 | -- |
| PDS Biotechnology Corp | 0.00 | -42.94m | 132.41m | 25.00 | -- | 4.57 | -- | -- | -1.39 | -1.39 | 0.00 | 0.7896 | 0.00 | -- | -- | 0.00 | -62.97 | -51.63 | -76.04 | -59.00 | -- | -- | -- | -- | -- | -33.04 | 0.4772 | -- | -- | -- | -5.11 | -- | -- | -- |
| CytoDyn Inc | 0.00 | -51.69m | 134.70m | 12.00 | -- | -- | -- | -- | -0.055 | -0.055 | 0.00 | -0.1206 | 0.00 | -- | -- | 0.00 | -414.98 | -259.98 | -- | -- | -- | -- | -- | -235,303.80 | -- | -0.88 | -- | -- | -100.00 | -- | 62.14 | -- | -- | -- |
| Omega Therapeutics Inc | 3.10m | -97.43m | 136.78m | 93.00 | -- | 2.36 | -- | 44.20 | -1.81 | -1.81 | 0.0573 | 1.05 | 0.0177 | -- | 0.9172 | 33,279.57 | -55.62 | -- | -64.61 | -- | -- | -- | -3,147.92 | -- | -- | -- | 0.2456 | -- | 49.25 | -- | 5.13 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to Molecular Partners AG's reporting currency: US Dollar USD
2.63%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BVF Partners LPas of 31 Dec 2023 | 443.22k | 1.22% |
| Suvretta Capital Management LLCas of 31 Dec 2023 | 400.00k | 1.10% |
| Tang Capital Management LLCas of 31 Dec 2023 | 100.00k | 0.28% |
| G1 Execution Services LLCas of 31 Dec 2023 | 12.62k | 0.04% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 367.00 | 0.00% |
| RhumbLine Advisers LPas of 31 Dec 2023 | 269.00 | 0.00% |
| Qube Research & Technologies Ltd.as of 31 Dec 2023 | 16.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Dec 2023 | 1.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
